Form 8-K - Current report:
SEC Accession No. 0001193125-22-144345
Filing Date
2022-05-09
Accepted
2022-05-09 08:07:33
Documents
17
Period of Report
2022-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d285541d8k.htm   iXBRL 8-K 34089
2 EX-10.1 d285541dex101.htm EX-10.1 19187
3 EX-10.2 d285541dex102.htm EX-10.2 74735
4 EX-99.1 d285541dex991.htm EX-99.1 10669
8 GRAPHIC g285541285541.jpg GRAPHIC 4082
9 GRAPHIC g285541g19j65.jpg GRAPHIC 3968
  Complete submission text file 0001193125-22-144345.txt   311461

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20220505.xsd EX-101.SCH 2850
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20220505_lab.xml EX-101.LAB 18737
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20220505_pre.xml EX-101.PRE 11703
11 EXTRACTED XBRL INSTANCE DOCUMENT d285541d8k_htm.xml XML 3472
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 22903324
SIC: 2834 Pharmaceutical Preparations